Generic Name and Formulations:
Cysteamine 0.44%; ophthalmic soln; contains benzalkonium chloride.
Sigma-Tau Pharmaceuticals, Inc.
Indications for CYSTARAN:
Treatment of corneal cystine cystal accumulation in patients with cystinosis.
Adults and Children:
Instill one drop in each eye every waking hour. Discard after 1 week of use.
Remove contact lenses prior to application; may reinsert after 15 mins. Pregnancy (Cat.C). Nursing mothers.
Light sensitivity, redness, eye pain/irritation, headache, visual field defects; possible benign intracranial hypertension.